These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 13319231)

  • 1. Antitumor effect of pluramycin crude powder on Ehrlich carcinoma of mice. Studies on antitumor substances produced by microorganisms. X.
    TAKEUCHI T; NITTA K; UMEZAWA H
    J Antibiot (Tokyo); 1956 Jan; 9(1):22-30. PubMed ID: 13319231
    [No Abstract]   [Full Text] [Related]  

  • 2. A new antitumor substance, pluramycin; studies on antitumor substances produced by Actinomycetes. XI.
    MAEDA K; TAKEUCHI T; NITTA K; YAGISHITA K; UTAHARA R; OSATO T; UEDA M; KONDO S; OKAMI Y; UMEZAWA H
    J Antibiot (Tokyo); 1956 Mar; 9(2):75-81. PubMed ID: 13345729
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of pluramycin A on Ehrlich carcinoma of mice; studies on antitumor substance produced by actinomycetes. XIII.
    TAKEUCHI T; HIKIJI T; NITTA K; UMEZAWA H
    J Antibiot (Tokyo); 1957 Jul; 10(4):143-52. PubMed ID: 13480934
    [No Abstract]   [Full Text] [Related]  

  • 4. Pluramycin complex with human serum albumin and the antitumor activity.
    Ogawara H; Maeda K; Umezawa H
    J Antibiot (Tokyo); 1966 Jul; 19(4):141-8. PubMed ID: 6013172
    [No Abstract]   [Full Text] [Related]  

  • 5. Largomycin FII chromophore component 4, a new pluramycin antibiotic.
    Byrne KM; Gonda SK; Hilton BD
    J Antibiot (Tokyo); 1985 Aug; 38(8):1040-9. PubMed ID: 4044405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the effects of actinomycin, cycloheximide, and other known antibiotics on Ehrlich carcinoma of mice.
    NITTA K; TAKEUCHI T; YAMAMOTO T; UMEZAWA H
    J Antibiot (Tokyo); 1955 Aug; 8(4):120-5. PubMed ID: 13286192
    [No Abstract]   [Full Text] [Related]  

  • 7. Further observations upon the cytostatic effects of sarkomycin: an experimental study on the Ehrlich ascites carcinoma in mice.
    ISHIYAMA S; HIRAYAMA H; TAKAMURA M; OHASHI T
    J Antibiot (Tokyo); 1955 Apr; 8(2):57-65. PubMed ID: 13242481
    [No Abstract]   [Full Text] [Related]  

  • 8. ANTITUMOR ACTIVITIES OF FORMYCIN AND LABILOMYCIN.
    ISHIZUKA M; TAKEUCHI T; NITTA K; KOYAMA G; HORI M; UMEZAWA H
    J Antibiot (Tokyo); 1964 May; 17():124-6. PubMed ID: 14171218
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
    Tanaka N
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANTITUMOR EFFECT OF ANTIBIOTIC OLIVOMYCIN.
    SHORIN VA; ROSSOLIMO OK; STANISLAVSKAYA MS; BLYUMBERG NA; FILIPPOSYAN ST; LEPESHKINA GN
    Fed Proc Transl Suppl; 1963; 22():1238-40. PubMed ID: 14079345
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on sarkomycin. VII. Effects of sarkomycin and related compounds on the anaerobic fermentation of Ehrlich ascites carcinoma cells of mice.
    AKITA E; HARA T; YAMADA Y
    J Antibiot (Tokyo); 1956 Sep; 9(5):191-2. PubMed ID: 13385197
    [No Abstract]   [Full Text] [Related]  

  • 12. ANTITUMOR ACTIVITY OF SHOWDOMYCIN.
    MATSUURA S; SHIRATORI O; KATAGIRI K
    J Antibiot (Tokyo); 1964 Nov; 17():234-7. PubMed ID: 14236202
    [No Abstract]   [Full Text] [Related]  

  • 13. STUDIES ON QUINOXALINE ANTIBIOTICS. IV. SELECTIVE ANTITUMOR ACTIVITY OF EACH QUINOXALINE ANTIBIOTIC.
    MATSUURA S
    J Antibiot (Tokyo); 1965 Jan; 18():43-6. PubMed ID: 14282372
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological studies on the antibiotics produced by Streptomyces griseoluteus. III. Effects of griseolutein B and the related compounds on Ehrlich carcinoma and HeLa cells.
    OGATA Y
    J Antibiot (Tokyo); 1959 Jul; 12():133-41. PubMed ID: 13854166
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental studies on chemotherapy of malignant tumors. III. Inhibitory effects of sarkomycin in a spectrum of ascites tumors in rats and mice.
    OBOSHI S; AOKI K; SAKURABA T; ISHIKURA T; YOSHIDA T; SATO M; SEKI K
    J Antibiot (Tokyo); 1955 Nov; 8(5):156-60. PubMed ID: 13306675
    [No Abstract]   [Full Text] [Related]  

  • 16. DAUNOMYCIN: A NEW ANTIBIOTIC WITH ANTITUMOR ACTIVITY.
    DIMARCO A; GAETANI M; DORIGOTTI L; SOLDATI M; BELLINI O
    Cancer Chemother Rep; 1964 May; 38():31-8. PubMed ID: 14167466
    [No Abstract]   [Full Text] [Related]  

  • 17. The antibiotics of the pluramycin group (4H-anthra[1,2-b]pyran antibiotics).
    Séquin U
    Fortschr Chem Org Naturst; 1986; 50():57-122. PubMed ID: 3546035
    [No Abstract]   [Full Text] [Related]  

  • 18. Antitumor effect of polysaccharide TC-13 on allogeneic and syngeneic tumors in mice.
    Kohno M; Abe S; Yamazaki M; Mizuno D
    Gan; 1982 Jun; 73(3):488-94. PubMed ID: 7129013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of 5-substituted 3-(1'-anilinoethylidene)pyrrolidine-2, 4-dione.
    Yuki H; Kitanaka E; Yamao A; Kariya K; Hashimoto Y
    Gan; 1971 Jun; 62(3):199-206. PubMed ID: 4998543
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on antitumor antibiotics.
    UMEZAWA H; TANAKA N; NITTA K; TAKEUCHI T
    Acta Unio Int Contra Cancrum; 1959; 15(Suppl 1)():295-6. PubMed ID: 13840348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.